Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 200-900-5 | CAS number: 75-77-4
Endpoint summary
Administrative data
Key value for chemical safety assessment
Effects on fertility
Effect on fertility: via inhalation route
- Dose descriptor:
- NOAEC
- 2 666 mg/m³
Additional information
Adverse effects following large acute exposures can be assumed to be caused by the hydrolysis product HCl. However, this is not the case for smaller repeated exposures (including reproductive toxicity). Potential adverse effects following such exposures could be due to the other hydrolysis product,trimethylsilanol, and it is therefore important to consider these potential adverse effects. Since there are no data for chlorotrimethylsilane itself, data on the hydrolysis product, trimethylsilanol have been used. However, when considering results of trimethylsilanol for read-across, it is important to assume local effects (irritation/corrosion) in addition to the effects observed for trimethylsilanol.
Short description of key information:
There are no data on the possible adverse effects of chlorotrimethylsilane on fertility. Therefore results from a key inhalation OECD 422 study on the hydrolysis product, trimethylsilanol have been read-across to support this endpoint for chlorotrimethylsilane. In this study trimethylsilanol did not have adverse effects on fertility up to concentrations of 600 ppm (2666 mg/m3).
Effects on developmental toxicity
Description of key information
There are no data on the possible adverse effects of chlorotrimethylsilane on development of offspring. Therefore results from a key inhalation OECD 422 study on the hydrolysis product, trimethylsilanol have been read-across to support this endpoint for chlorotrimethylsilane. In this study trimethylsilanol did not have adverse effects on development up to concentrations of 600 ppm (2666 mg/m3).
Effect on developmental toxicity: via inhalation route
- Dose descriptor:
- NOAEC
- 2 666 mg/m³
Additional information
It is considered appropriate to use this reliable result in support of the developmental toxicity endpoint for chlorotrimethylsilane as this substance is hydrolysed very rapidly in the presence of moisture to trimethylsilanol and hydrogen chloride.
Since chlorotrimethylsilane is hydrolysed to trimethylsilane and hydrogen chloride, additional local irritation can be expected due to the acidic nature of the HCl.
Toxicity to reproduction: other studies
Additional information
Adverse effects following large acute exposures can be assumed to be caused by the hydrolysis product HCl. However, this is not the case for smaller repeated exposures (including developmental toxicity). Potential adverse effects following such exposures could be due to the other hydrolysis product,trimethylsilanol, and it is therefore important to consider these potential adverse effects. Since there are no data for chlorotrimethylsilane itself, data on the hydrolysis product, trimethylsilanol have been used. However, when considering results of trimethylsilanol for read-across, it is important to assume local effects (irritation/corrosion) in addition to the effects observed for trimethylsilanol.
.
Justification for classification or non-classification
Additional information
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
